HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peptide-based approaches to treat lupus and other autoimmune diseases.

Abstract
After a long period where the potential of therapeutic peptides was let into oblivion and even dismissed, there is a revival of interest in peptides as potential drug candidates. Novel strategies for limiting metabolism and improve their bioavailability, and alternative routes of administration have emerged. This resulted in a large number of peptide-based drugs that are now being marketed in different indications. Regarding autoimmunity, successful data have been reported in numerous mouse models of autoimmune inflammation, yet relatively few clinical trials based on synthetic peptides are currently underway. This review reports on peptides that show much promises in appropriate mouse models of autoimmunity and describes in more detail clinical trials based on peptides for treating autoimmune patients. A particular emphasis is given to the 21-mer peptide P140/Lupuzor that has completed successfully phase I, phase IIa and phase IIb clinical trials for systemic lupus erythematosus.
AuthorsNicolas Schall, Nicolas Page, Christophe Macri, Olivier Chaloin, Jean-Paul Briand, Sylviane Muller
JournalJournal of autoimmunity (J Autoimmun) Vol. 39 Issue 3 Pg. 143-53 (Sep 2012) ISSN: 1095-9157 [Electronic] England
PMID22727561 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Immunologic Factors
  • Peptide Fragments
  • spliceosomal peptide P140
Topics
  • Amino Acid Sequence
  • Animals
  • Autoimmune Diseases (drug therapy, immunology)
  • Autoimmunity (drug effects)
  • Biological Availability
  • Clinical Trials as Topic
  • Drug Administration Routes
  • Drug Administration Schedule
  • Humans
  • Immunologic Factors (administration & dosage, pharmacokinetics)
  • Lupus Erythematosus, Systemic (drug therapy, immunology, mortality)
  • Mice
  • Molecular Sequence Data
  • Peptide Fragments (administration & dosage, pharmacokinetics)
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: